Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiotherapy-induced ear toxicity.

Barbara A Jereczek-Fossa1, Andrzej Zarowski, Franco Milani

  • 1Division of Radiation Oncology of the European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy. barbara.fossa@ieo.it

Cancer Treatment Reviews
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

The Lancet. Oncology·2026
Same author

Magnetic Resonance Imaging Detection of Secondary Endolymphatic Hydrops in a DFNA9 Patient With Sudden Deafness.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026
Same author

Prevalence of Dental Caries in Adults Scheduled for Hematopoietic Stem Cell Transplantation: A Multicenter Study in a Polish Population.

Cancers·2026
Same author

Stereotactic arrhythmia radioablation for refractory ventricular tachycardia: the STOPSTORM.eu study.

European heart journal·2026
Same author

Efficacy and tolerability of hypofractionated and dose-boosted radiotherapy for localised prostate cancer: a systematic review and meta-analysis.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration.

The Lancet. Oncology·2026
Same journal

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective.

Cancer treatment reviews·2026
Same journal

Treatment of breast cancer brain metastases in the era of novel drugs.

Cancer treatment reviews·2026
Same journal

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Cancer treatment reviews·2026
Same journal

Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer.

Cancer treatment reviews·2026
Same journal

Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.

Cancer treatment reviews·2026
Same journal

Early onset pancreatic Cancer: epidemiology, molecular features, and clinical outcomes.

Cancer treatment reviews·2026
See all related articles

Radiotherapy can cause significant ear injuries, including hearing loss, affecting up to 40% of patients. Minimizing radiation dose to the ear and advancing techniques can improve prevention and management of these auditory side effects.

Area of Science:

  • Otolaryngology
  • Radiation Oncology
  • Audiology

Background:

  • Radiotherapy-induced ear injuries are under-reported and can lead to various types of hearing loss.
  • Acute and late effects can impact all auditory structures, with sensorineural hearing loss (SNHL) affecting up to one-third of patients.

Purpose of the Study:

  • To review the incidence, risk factors, and management strategies for radiotherapy-induced ear injuries.
  • To highlight the importance of dose reduction to auditory structures and advancements in radiotherapy techniques.

Main Methods:

  • Literature review of radiotherapy-induced ototoxicity.
  • Analysis of factors influencing hearing impairment risk.
  • Overview of current and emerging treatment modalities for auditory complications.

Related Experiment Videos

Main Results:

  • Total radiation dose and tumor site are key factors in hearing impairment risk.
  • Advanced radiotherapy techniques (IMRT, proton therapy) offer better dose distribution.
  • Management includes conservative treatments for otitis, hearing aids for functional deficits, and debated therapies for SNHL.

Conclusions:

  • Reducing radiation dose to auditory structures is crucial.
  • New radiotherapy techniques can minimize ototoxicity.
  • Further research in otologic diagnostics and therapy is needed for better prevention and management of radiation-related acoustic injury.